Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

Investor Optimism Improves Ahead Of Key Inflation Data

By Lisa Levin

January 12, 5:06 AM

The CNN Money Fear and Greed index showed further improvement in the market sentiment among US investors. US stocks closed higher on Wednesday, with the Nasdaq recording gains for the fourth straight session.

INFY

‘Supreme Court says Biden cannot reinstate policy limiting ICE arrests, for now’ -Washington Post Report

By Benzinga Newsdesk

July 21, 5:22 PM

https://www.washingtonpost.com/national-security/2022/07/21/supreme-court-biden-ice-immigration-enforcement/

SPY

News

‘Rackspace Technology Launches Foundry For Generative AI By Rackspace’

By Benzinga Newsdesk

June 13, 10:13 AM

https://www.rackspace.com/newsroom/rackspace-technology-launches-foundry-generative-ai-rackspace

RTX

News

VinFast Unveils EV Innovations: Debut of New Concept, Mini eSUV VF 3, and DrgnFly Electric Bikes at CES 2024

By Benzinga Newsdesk

December 26, 7:35 AM

VinFast Auto (NASDAQ:VFS) announces its participation in CES 2024, one of the most powerful tech events in the world, taking place from January 9 - 12, 2024 at the Las Vegas Convention Center.

VFS

Oppenheimer Downgrades CinCor Pharma to Perform

Related Posts

Investor Optimism Improves Ahead Of Key Inflation Data

‘Supreme Court says Biden cannot reinstate policy limiting ICE arrests, for now’ -Washington Post Report

‘Rackspace Technology Launches Foundry For Generative AI By Rackspace’

VinFast Unveils EV Innovations: Debut of New Concept, Mini eSUV VF 3, and DrgnFly Electric Bikes at CES 2024